summaryrefslogtreecommitdiff
path: root/derivation_to_json/before.json
blob: 1d2c9114fbee03a7656a992bbdca8d46108ac448 (plain)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
{
  "phrase_alignment": [
    [
      1
    ],
    [
      2,
      0
    ],
    [
      3
    ],
    [
      4
    ],
    [
      5
    ],
    [
      6
    ],
    [
      7
    ],
    [
      8
    ],
    [
      9
    ],
    [
      10
    ],
    [
      11
    ],
    [
      12
    ],
    [
      13
    ],
    [
      14
    ]
  ],
  "source_rgroups": [
    4,
    3,
    7,
    6,
    5,
    8,
    9,
    11,
    12,
    13,
    10,
    9,
    8,
    14
  ],
  "target_rgroups": [
    3,
    4,
    3,
    7,
    6,
    5,
    8,
    9,
    11,
    12,
    13,
    10,
    9,
    8,
    14
  ],
  "rules_by_span_id": {
    "4": "[X] ||| weiterhin gehört ||| also ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=0.458975 MaxLexFgivenE=4.79441 CountEF=0.30103 SampleCountF=0.477121 EgivenFCoherent=0.30103 ||| 0-0 1-0\n",
    "3": "[X] ||| [X] zur Erfindung [X] ||| the invention [X] relates to [X] ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=0 MaxLexEgivenF=3.63316 MaxLexFgivenE=1.80404 CountEF=0.30103 SampleCountF=1.27875 EgivenFCoherent=1.25527 ||| 1-4 2-3\n",
    "7": "[X] ||| die Verwendung dieser Zusammensetzungen zur ||| the use of said compositions for the ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=2.93053 MaxLexFgivenE=3.26928 CountEF=0.30103 SampleCountF=0.69897 EgivenFCoherent=0.60206 ||| 0-0 1-1 2-3 3-4 4-5\n",
    "6": "[X] ||| [X] Therapie und Prophylaxe von ||| [X] therapy and prophylaxis of ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.926982 MaxLexFgivenE=1.42237 CountEF=0.90309 SampleCountF=1.47712 EgivenFCoherent=0.6173 ||| 1-1 2-2 3-3 4-4\n",
    "5": "[X] ||| [X] Herz-Kreislauf-Erkrankungen ||| [X] cardiovascular diseases ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.739399 MaxLexFgivenE=0.797149 CountEF=1.38021 SampleCountF=1.69897 EgivenFCoherent=0.328468 ||| 1-1 1-2\n",
    "8": "[X] ||| , Erkrankungen [X] Krebserkrankungen [X] ||| , diseases [X] cancerous diseases [X] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.3856 MaxLexFgivenE=0.862494 CountEF=0.477121 SampleCountF=0.778151 EgivenFCoherent=0.39794 ||| 0-0 1-1 3-3 3-4\n",
    "9": "[X] ||| im Zusammenhang [X] oder ||| in conjunction [X] or ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.43987 MaxLexFgivenE=2.45332 CountEF=0.778151 SampleCountF=1.44716 EgivenFCoherent=0.732394 ||| 0-0 1-1 3-3\n",
    "11": "[X] ||| mit einer erhöhten [X] ||| with an increased [X] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.72017 MaxLexFgivenE=2.04771 CountEF=0.954243 SampleCountF=1.6902 EgivenFCoherent=0.778151 ||| 0-0 1-1 2-2\n",
    "12": "[X] ||| Thrombozytenaggregation , [X] ||| platelet aggregation [X] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.886057 MaxLexFgivenE=1.98654 CountEF=0.477121 SampleCountF=0.69897 EgivenFCoherent=0.30103 ||| 0-0 0-1\n",
    "13": "[X] ||| Stoffwechsel-Erkrankungen ||| asdf ||| ForceRule=1 ||| 0-0\n",
    "10": "[X] ||| [X] , Knochenerkrankungen ||| [X] , osteopathy ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=1.11792 MaxLexFgivenE=0.186321 CountEF=0.30103 SampleCountF=0.30103 EgivenFCoherent=-0 ||| 1-1 2-2\n",
    "14": "[X] ||| . ||| . ||| IsSupportedOnline=1 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.0201086 MaxLexFgivenE=0.135104 CountEF=2.39967 SampleCountF=2.48287 EgivenFCoherent=0.0835026 ||| 0-0\n"
  },
  "source_groups": [
    "weiterhin gehört",
    "zur Erfindung",
    "die Verwendung dieser Zusammensetzungen zur",
    "Therapie und Prophylaxe von",
    "Herz-Kreislauf-Erkrankungen",
    ", Erkrankungen",
    "im Zusammenhang",
    "mit einer erhöhten",
    "Thrombozytenaggregation ,",
    "Stoffwechsel-Erkrankungen",
    ", Knochenerkrankungen",
    "oder",
    "Krebserkrankungen",
    "."
  ],
  "target_groups": [
    "the invention",
    "also",
    "relates to",
    "the use of said compositions for the",
    "therapy and prophylaxis of",
    "cardiovascular diseases",
    ", diseases",
    "in conjunction",
    "with an increased",
    "platelet aggregation",
    "asdf",
    ", osteopathy",
    "or",
    "cancerous diseases",
    "."
  ]
}